{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:43:02Z","timestamp":1788205382461,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.4158\/ep172000.or","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T11:03:30Z","timestamp":1521198210000},"page":"243-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lanreotide Therapy in Carcinoid Syndrome: Prospective Analysis of Patient-Reported Symptoms in Patients Responsive To Prior Octreotide Therapy And Patients Na\u00efve To Somatostatin Analogue Therapy in The Elect Phase 3 Study"],"prefix":"10.1016","volume":"24","author":[{"suffix":"Jr.","given":"George A.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Wolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilani","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Pitman","family":"Lowenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beloo","family":"Mirakhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney F.","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montaser","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron I.","family":"Vinik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP172000.OR_bb0010","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/jc.2015-1215","article-title":"Effects of TZD use and discontinuation on fracture rates in ACCORD bone study","volume":"100","author":"Schwartz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2121-8-51","article-title":"Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells","volume":"8","author":"Kanazawa","year":"2007","journal-title":"BMC Cell Biol"},{"key":"10.4158\/EP172000.OR_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0953-6205(02)00183-8","article-title":"Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients","volume":"14","author":"Jehle","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.4158\/EP172000.OR_bb0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.4158\/EP172000.OR_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1359\/jbmr.1998.13.6.1045","article-title":"Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women","volume":"13","author":"Ricci","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0040","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/oby.21150","article-title":"Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy","volume":"23","author":"Maghrabi","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.4158\/EP172000.OR_bb0045","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/jbmr.2564","article-title":"Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials","volume":"30","author":"Zibellini","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0050","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.1999.14.8.1404","article-title":"Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures","volume":"14","author":"Bauer","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0060","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11695-009-0028-z","article-title":"Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density","volume":"20","author":"Balsa","year":"2010","journal-title":"Obes Surg"},{"key":"10.4158\/EP172000.OR_bb0070","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/dom.12363","article-title":"Skeletal effects of bariatric surgery: examining bone loss, potential mechanisms and clinical relevance","volume":"16","author":"Scibora","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP172000.OR_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11695-015-1724-5","article-title":"Changes in bone metabolism in morbidly obese patients after bariatric surgery: a meta-analysis","volume":"26","author":"Liu","year":"2016","journal-title":"Obes Surg"},{"key":"10.4158\/EP172000.OR_bb0080","doi-asserted-by":"crossref","first-page":"e2087","DOI":"10.1097\/MD.0000000000002087","article-title":"Fracture risk after bariatric surgery: a 12-year nationwide cohort study","volume":"94","author":"Lu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP172000.OR_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00198-013-2463-x","article-title":"Fracture risk following bariatric surgery: a population-based study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP172000.OR_bb0090","doi-asserted-by":"crossref","first-page":"i3794","DOI":"10.1136\/bmj.i3794","article-title":"Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study","volume":"354","author":"Rousseau","year":"2016","journal-title":"BMJ"},{"key":"10.4158\/EP172000.OR_bb0095","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4158\/EP172000.OR_bb0100","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2009-2128","article-title":"Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline","volume":"95","author":"Heber","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0105","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00198-016-3561-3","article-title":"The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club","volume":"27","author":"Cavalier","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP172000.OR_bb0110","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1210\/jc.2008-0481","article-title":"The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss","volume":"93","author":"Fleischer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0115","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jbmr.2707","article-title":"The impact of vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study","volume":"31","author":"Muschitz","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s11695-014-1509-2","article-title":"Markers of bone metabolism in obese individuals undergoing laparoscopic sleeve gastrectomy","volume":"25","author":"Schollenberger","year":"2015","journal-title":"Obes Surg"},{"key":"10.4158\/EP172000.OR_bb0125","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.soard.2014.06.018","article-title":"Effects of laparoscopic Roux-en-Y gastric bypass on bone mineral density and markers of bone turnover","volume":"10","author":"Obinwanne","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"10.4158\/EP172000.OR_bb0130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s11695-017-2546-4","article-title":"Bariatric Roux-en-Y gastric bypass surgery: adipocyte proteins involved in increased bone remodeling in humans","volume":"27","author":"Biagioni","year":"2017","journal-title":"Obes Surg"},{"key":"10.4158\/EP172000.OR_bb0135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/jc.2012-2394","article-title":"Bariatric surgery results in cortical bone loss","volume":"98","author":"Stein","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0140","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.soard.2012.08.006","article-title":"Effects of surgically induced weight loss by Roux-en-Y gastric bypass on osteocalcin","volume":"9","author":"Maser","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.4158\/EP172000.OR_bb0145","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/jc.2015-3437","article-title":"Effects of gastric bypass and gastric banding on bone remodeling in obese patients with type 2 diabetes","volume":"101","author":"Yu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bone.2016.11.001","article-title":"Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy","volume":"95","author":"Ivaska","year":"2017","journal-title":"Bone"},{"key":"10.4158\/EP172000.OR_bb0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jc.2014-2646","article-title":"Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study","volume":"100","author":"Chubb","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP172000.OR_bb0160","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/oby.2011.133","article-title":"Increased PTH and 1.25(OH) (2)D levels associated with increased markers of bone turnover following bariatric surgery","volume":"19","author":"Sinha","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.4158\/EP172000.OR_bb0165","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jbmr.2063","article-title":"Bone loss after bariatric surgery: discordant results between DXA and QCT bone density","volume":"29","author":"Yu","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP172000.OR_bb0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2016.12.012","article-title":"Vitamin D and intestinal calcium transport after bariatric surgery","volume":"173","author":"Schafer","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.4158\/EP172000.OR_bb0175","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ijo.2012.115","article-title":"Bariatric surgery and bone disease: from clinical perspective to molecular insights","volume":"36","author":"Folli","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.4158\/EP172000.OR_bb0180","doi-asserted-by":"crossref","first-page":"e40038","DOI":"10.1371\/journal.pone.0040038","article-title":"Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology","volume":"7","author":"Wong","year":"2012","journal-title":"PloS One"},{"key":"10.4158\/EP172000.OR_bb0185","first-page":"97","article-title":"Influence of weight reduction on leptin concentration and bone mineral density in patients with morbid obesity before and 6 months after bariatric surgery [in Polish]","volume":"60","author":"Walicka","year":"2009","journal-title":"Endokrynol Pol"},{"key":"10.4158\/EP172000.OR_bb0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00004183","article-title":"Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy","volume":"11","author":"Fink","year":"2000","journal-title":"Osteoporosis Int"},{"issue":"3 suppl","key":"10.4158\/EP172000.OR_bb0195","doi-asserted-by":"crossref","first-page":"197S","DOI":"10.1016\/8756-3282(95)00502-1","article-title":"Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy","volume":"18","author":"Riggs","year":"1996","journal-title":"Bone"},{"key":"10.4158\/EP172000.OR_bb0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP172000.OR_bb0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/dom.12860","article-title":"Canagliflozin versus placebo for post-bariatric surgery patients with persistent type II diabetes: a randomized controlled trial (CARAT)","volume":"19","author":"Kheniser","year":"2017","journal-title":"Diabetes Obes Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:10Z","timestamp":1761516370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20357517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1530891X20357517"],"URL":"https:\/\/doi.org\/10.4158\/ep172000.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lanreotide Therapy in Carcinoid Syndrome: Prospective Analysis of Patient-Reported Symptoms in Patients Responsive To Prior Octreotide Therapy And Patients Na\u00efve To Somatostatin Analogue Therapy in The Elect Phase 3 Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP172000.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}